BusinessWorld Online
Philippines hopeful of vaccine manufacturing investments by 2022
The Philippines may achieve local vaccine production capabilities by the end of 2022, according to a Department of Science and Technology (DOST) official.
DOST Undersecretary Rowena Guevara indicated that two of the six local firms in discussions with the government are progressing rapidly with their vaccine manufacturing plans.
She stated that these companies could potentially begin producing vaccines by late 2022 if they maintain their aggressive approach.
A fill-finish facility, which involves packaging bulk antigens into final vaccine doses, can be established in less than two years.
Establishing a full-scale vaccine manufacturing facility, however, would require a minimum of three years for a local company in partnership with a foreign manufacturer.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Glovax Biotech Corp. announced a partnership with businessman Manuel V. Pangilinan to establish a COVID-19 vaccine manufacturing plant in the Philippines.
Read more →
President Rodrigo Duterte has approved the Department of Trade and Industry's (DTI) request to provide assistance to potential local vaccine manufacturers in the Philippines.
Read more →
The Philippines expects over five million doses of coronavirus vaccines in the second quarter to accelerate its immunization program amidst a surge in infections.
+2
Read more →
The Philippines is anticipating the arrival of Pfizer and Moderna COVID-19 vaccine doses in May and June, according to Manila's Ambassador to Washington Jose Manuel Romualdez.
Read more →
The Philippines is expected to receive about 20 million doses of Russia's Sputnik V COVID-19 vaccine within 2021.
Read more →